Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination

Mycobacterium abscessus is a rapidly emerging mycobacterial pathogen causing dangerous pulmonary infections. Because these bacteria are intrinsically multidrug resistant, treatment options are limited and have questionable efficacy. The current treatment regimen relies on a combination of antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pryjma, Mark, Burian, Ján, Thompson, Charles J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105836/
https://www.ncbi.nlm.nih.gov/pubmed/29760147
http://dx.doi.org/10.1128/AAC.00283-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105836/
https://www.ncbi.nlm.nih.gov/pubmed/29760147
http://dx.doi.org/10.1128/AAC.00283-18

Ejemplares similares